Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Giant Cell Tumor of Bone 2 Breast Neoplasms 2 Thyroid Cancer Metastatic 1 Osteoporotic Fractures 1 Osteoporosis 1 Osteopetrosis, mild autosomal recessive form 1 Osteopetrosis, Autosomal Recessive 7 1 Osteoblastoma 1 Neoplasm Metastasis 1 Musculoskeletal Pain 1 Melanoma 1 Kidney Neoplasms 1 Granuloma, Giant Cell 1 Chondroblastoma 1 Carcinoma, Renal Cell 1 Bone Metastasis From Solid Tumors 1 Bone Metastases From Solid Tumors 1 Bone Metastases 1 Bone Cysts, Aneurysmal 1 Arthralgia 1

Interventions

Nivolumab 25 pembrolizumab 20 Ipilimumab 15 toripalimab 12 Temozolomide 11 Biopsy 8 Dacarbazine 7 Cyclophosphamide 6 Blood Specimen Collection 6 trametinib 5 fludarabine 5 dabrafenib 5 camrelizumab 5 atezolizumab 5 Gene Expression Profiling 5 Chemotherapy, Adjuvant 5 durvalumab 4 binimetinib 4 aldesleukin 4 Interleukin-2 4 Injections 4 Carboplatin 4 tislelizumab 3 palbociclib 3 encorafenib 3 apatinib 3 Sorafenib 3 Paclitaxel 3 Introns 3 Drug Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Melanoma × Denosumab × Clear all

NCT03161756 2022-04-07

CHARLI

Melanoma and Skin Cancer Trials Limited

Phase 1/2 Unknown

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡